Join the Study

Nos Actualités

Home
Nos Actualités
News
18 September 2026

  Alzheimer’s: the ALZEVIT study is recruiting 50,000 volunteers in France

The ALZEVIT study was launched on 10 September 2026 in Paris. It is seeking 50,000 volunteers aged 45 and over, across France, to build the first national registry of the APOE gene. Online registration, saliva kit at home, free participation....
Read More
APO-Easy Genotyping kit for Alzheimer's Disease diagnostic
News
20 August 2024

  Amoneta Diagnostics gains CE-marking for APO-Easy® Genotyping Kit under EU IVDR

Amoneta announces the CE-marking under the EU-IVDR of its APO-Easy® Genotyping Kit....
Read More
Events
27 March 2025

Amoneta Diagnostics at AD/PD™ 2025: APO-Easy® Genotyping kit in the Context of New Therapies’ Launch

Amoneta Diagnostics is pleased to announce its’ team’s participation to the AD/PD™ 2025 conference, a major international event that brings together experts in the field of Alzheimer’s and Parkinson’s disease. This year, the focus will be on APO-Easy®, our CE-IVDR certified genotyping kit that is designed to assess genetic risk for Alzheimer’s disease through the analysis of the APOE gene. With the launch of groundbreaking new treatments for Alzheimer’s disease, the need for ident...
Read More
ctad
Events
22 October 2024

Amoneta at CTAD 2024: Introducing our Research on Advancing Alzheimer’s Disease Stratification

We are excited to announce that our team will not only be attending but also presenting at the 2024 Clinical Trials on Alzheimer’s Disease (CTAD) conference. During the second poster session on October 31st, we will present our poster number 00492, which introduces an innovative approach to Alzheimer’s patient stratification by combining “static” genetic data from our APO-Easy® and NeuroDeGene® genotyping tools, with dynamic biomarker signatures through AI algorithms. Our resea...
Read More
ad/pd international conference amoneta diagnostics exhibitor
Events
14 February 2024

Amoneta Diagnostics attends the AD/PD™ 2024 International Conference

Amoneta Diagnostics announces its participation in the forthcoming AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases in Lisbon....
Read More